Literature DB >> 24726309

Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats.

Krystyna Ossowska1, Jadwiga Wardas2, Klemencja Berghauzen-Maciejewska2, Urszula Głowacka2, Katarzyna Kuter2, Andrzej Pilc3, Stevin H Zorn4, Dario Doller4.   

Abstract

Harmaline induces tremor in animals resembling essential tremor which has been suggested to result from activation of the glutamatergic olivo-cerebellar projection. The aim of the present study was to examine the effects of systemic administration of Lu AF21934, a brain-penetrating positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu4), on the harmaline-induced tremor and other forms of motor activity in rats using fully automated Force Plate Actimeters. The influence of harmaline on the mGlu4 mRNA expression in the cerebellum and inferior olive was analysed by in situ hybridization. Harmaline at a dose of 15 mg/kg (ip) triggered tremor which was manifested by an increase in the power within 9-15 Hz band and in the tremor index (a difference in power between bands 9-15 Hz and 0-8 Hz). Harmaline induced a biphasic effect on mobility, initially inhibiting the exploratory locomotor activity of rats (0-30 min after administration), followed by an increase in their basic activity. Lu AF21934 (0.5-5 mg/kg sc) did not influence tremor but at doses of 0.5 and 2.5 mg/kg reversed harmaline-induced hyperactivity. MGlu4 mRNA expression was high in the cerebellar cortex and low in the inferior olive. Repeated harmaline (15 mg/kg ip once a day for 5 days] decreased mGlu4 mRNA in the cerebellum and inferior olive. The present study indicates that the mGlu4 stimulation counteracts hyperactivity induced by harmaline which suggests the involvement of cerebellar glutamatergic transmission in this process. In contrast, neuronal mechanisms involved in tremor seem to be insensitive to the stimulation of mGlu4.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebellum; Harmaline; Hyperactivation; Inferior olive; Metabotropic glutamate receptor 4; Tremor

Mesh:

Substances:

Year:  2014        PMID: 24726309     DOI: 10.1016/j.neuropharm.2014.03.018

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

1.  Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Neuropharmacology       Date:  2015-02       Impact factor: 5.250

2.  Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Pharmacol Rep       Date:  2016-02-05       Impact factor: 3.024

3.  Tremorolytic effect of 5'-chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline-induced model in rats.

Authors:  Barbara Kosmowska; Krystyna Ossowska; Urszula Głowacka; Jadwiga Wardas
Journal:  CNS Neurosci Ther       Date:  2017-03-29       Impact factor: 5.243

Review 4.  Neuroscience and actometry: An example of the benefits of the precise measurement of behavior.

Authors:  Troy J Zarcone
Journal:  Brain Res Bull       Date:  2022-04-25       Impact factor: 3.715

5.  Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Donald E Mager; Stephan Schmidt; Ai-Ming Yu
Journal:  Acta Pharm Sin B       Date:  2016-08-06       Impact factor: 11.413

6.  Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish.

Authors:  Robson Savoldi; Daniel Polari; Jaquelinne Pinheiro-da-Silva; Priscila F Silva; Bruno Lobao-Soares; Mauricio Yonamine; Fulvio A M Freire; Ana C Luchiari
Journal:  Front Behav Neurosci       Date:  2017-07-28       Impact factor: 3.558

7.  Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7.

Authors:  Nidhi Jalan-Sakrikar; Julie R Field; Rebecca Klar; Margrith E Mattmann; Karen J Gregory; Rocio Zamorano; Darren W Engers; Sean R Bollinger; C David Weaver; Emily L Days; L Michelle Lewis; Thomas J Utley; Miguel Hurtado; Delphine Rigault; Francine Acher; Adam G Walker; Bruce J Melancon; Michael R Wood; Craig W Lindsley; P Jeffrey Conn; Zixiu Xiang; Corey R Hopkins; Colleen M Niswender
Journal:  ACS Chem Neurosci       Date:  2014-10-09       Impact factor: 4.418

8.  Challenges in the Discovery and Optimization of mGlu2/4 Heterodimer Positive Allosteric Modulators.

Authors:  Mark Gallant Fulton; Matthew Thomas Loch; Caroline Anne Cuoco; Alice Lambert Rodriguez; Emily Days; Paige Newton Vinson; Krystian Andrezej Kozek; Charles David Weaver; Anna Louise Blobaum; Peter Jeffrey Conn; Colleen Marie Niswender; Craig William Lindsley
Journal:  Lett Drug Des Discov       Date:  2019-12       Impact factor: 1.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.